Maury Raycroft
Stock Analyst at Jefferies
(1.61)
# 3,425
Out of 5,182 analysts
59
Total ratings
35.56%
Success rate
-1.94%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $36.92 | +16.47% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $87.16 | -7.07% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $23.99 | +162.61% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.28 | +78.44% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $125.68 | +6.62% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $16.37 | +28.28% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.20 | +33.33% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $308.51 | +77.95% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $7.29 | -3.98% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $44.11 | -65.99% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.72 | +103.49% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $10.08 | +425.79% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.79 | +346.93% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.21 | +1,328.57% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $19.15 | -68.67% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $26.33 | -27.84% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $3.67 | +308.72% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $17.93 | +903.90% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.49 | +1,448.82% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $1.72 | +11,237.21% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $8.90 | +23.60% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $37.28 | -83.91% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $73.60 | +1.90% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.31 | +232.33% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.56 | +220.51% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $5.49 | +555.74% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $7.50 | +1,300.00% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $50.99 | +237.32% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.92 | +1,509.59% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $13.04 | +222.09% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $36.92
Upside: +16.47%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $87.16
Upside: -7.07%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $23.99
Upside: +162.61%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.28
Upside: +78.44%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $125.68
Upside: +6.62%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $16.37
Upside: +28.28%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.20
Upside: +33.33%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $308.51
Upside: +77.95%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $7.29
Upside: -3.98%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $44.11
Upside: -65.99%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.72
Upside: +103.49%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $10.08
Upside: +425.79%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $1.79
Upside: +346.93%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.21
Upside: +1,328.57%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $19.15
Upside: -68.67%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $26.33
Upside: -27.84%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $3.67
Upside: +308.72%
Mar 13, 2024
Initiates: Buy
Price Target: $180
Current: $17.93
Upside: +903.90%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.49
Upside: +1,448.82%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $1.72
Upside: +11,237.21%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $8.90
Upside: +23.60%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $37.28
Upside: -83.91%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $73.60
Upside: +1.90%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.31
Upside: +232.33%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.56
Upside: +220.51%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $5.49
Upside: +555.74%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $7.50
Upside: +1,300.00%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $50.99
Upside: +237.32%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.92
Upside: +1,509.59%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $13.04
Upside: +222.09%